Long-Term Clinical and Economic Impact of Automated Insulin Delivery Systems Use in Pediatric and Adolescents Type 1 Diabetes: Results Across Australia, Canada, the UK, and the USA

Citation:
Legault L, Sherr JL, Davis EA, Cerezales M, et al. Long-Term Clinical and Economic Impact of Automated Insulin Delivery Systems Use in Pediatric and Adolescents Type 1 Diabetes: Results Across Australia, Canada, the UK, and the USA. Diabetes Technol Ther. 2026.

Keywords:
Type 1; adolescents; automated; children; cost-effectiveness analysis; diabetes complications; diabetes mellitus; glycemic control; insulin infusion systems.

Abstract:
Automated Insulin Delivery (AID) systems are the recommended standard of care for Type 1 Diabetes (T1D) management in children and adolescents, according to latest international guidelines. This study aims to assess the cost-effectiveness of AID systems for pediatric T1D care in Australia, Canada, the United Kingdom, and the United States.